Panagora Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Panagora Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$892K	Buy	199,145 +32,434	+19%	+$162K	﹤0.01%	734
2025 Q4	$879K	Buy	166,711 +6,154	+4%	+$31K	﹤0.01%	755
2025 Q3	$848K	Buy	+160,557	New	+$1.02M	﹤0.01%	693
2021 Q3	–	Sell	-105	Closed	-$4K	–	1696
2021 Q2	$4K	Sell	105 -687	-87%	-$28K	﹤0.01%	2514
2021 Q1	$37K	Buy	792 +687	+654%	+$37.8K	﹤0.01%	2234
2020 Q4	$4K	Buy	+105	New	+$3.58K	﹤0.01%	2504
2020 Q3	–	Sell	-145	Closed	-$11K	–	2690
2020 Q2	$11K	Buy	+145	New	+$10K	﹤0.01%	2230

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Panagora Asset Management's ABEO Position: Q1 2026 in Review

Panagora Asset Management increased its Abeona Therapeutics (ABEO) stake by 19% in Q1 2026, buying an estimated $162K and bringing the position to 199,145 shares worth $892K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Panagora Asset Management first reported a position in ABEO in Q2 2020 and has held it in 7 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

Panagora Asset Management held 199,145 shares of Abeona Therapeutics worth $892K as of Q1 2026.
Panagora Asset Management bought 32,434 Abeona Therapeutics shares in Q1 2026, an estimated $162K.
Abeona Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #734 holding.
Panagora Asset Management first reported a position in Abeona Therapeutics in Q2 2020 and has held it in 7 quarters since.
108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.